TP-102 compassionate uses cases presented at ECCMID 2023

TP-102 compassionate uses cases presented at ECCMID 2023

Last month Technophage team attended ECCMID 2023, and together with the clinical team from Israel, we have presented the results from two cases of compassionate use carried out in Israel, under the supervision of Dra. Michal Deckel. – Case study 1 showed a...
Technophage patent portfolio

Technophage patent portfolio

TechnoPhage is currently working on several projects in different therapeutic areas, such as infection, ophthalmology, or neuroscience, among which numerous patents have been placed throughout the years. Did you know that the total number of ‘live’ patents...
Technophage featured in ‘The Business Year Portugal 2022’

Technophage featured in ‘The Business Year Portugal 2022’

This year Technophage has been featured in the Portuguese edition of The Business Year. The publication was based on more than 130 face-to-face interviews with leading #investors, business leaders, and government representatives from all the key sectors driving...
Technophage granted with the ‘COTEC Innovative Status 2022′

Technophage granted with the ‘COTEC Innovative Status 2022′

Technophage is proud to announce that it has recently been granted with the ‘COTEC Innovative Status 2022’. COTEC Portugal is the main Portuguese business association for the promotion of business innovation and technological cooperation. The COTEC Innovative Status...